VALYSTR · Stock research
Listed on NasdaqGS. What the market is pricing into Royalty Pharma plc (RPRX) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Pharmaceuticals · market value about $38.4B · P/E 35.3 · revenue $2.5B (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows